INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $527,000 | +235.7% | 100,000 | +400.0% | 0.05% | +283.3% |
Q4 2015 | $157,000 | -53.6% | 20,000 | -50.0% | 0.01% | -14.3% |
Q3 2015 | $338,000 | -24.7% | 40,000 | -2.4% | 0.01% | -48.1% |
Q2 2015 | $449,000 | -47.4% | 41,000 | -32.8% | 0.03% | -59.1% |
Q1 2015 | $853,000 | +229.3% | 61,000 | +298.1% | 0.07% | +200.0% |
Q4 2014 | $259,000 | -94.6% | 15,323 | -95.6% | 0.02% | -96.2% |
Q4 2013 | $4,834,000 | -29.0% | 350,000 | -10.3% | 0.58% | +107.5% |
Q3 2013 | $6,804,000 | +275.3% | 390,310 | +248.7% | 0.28% | +53.0% |
Q2 2013 | $1,813,000 | – | 111,940 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |